Taohua Yue

811 total citations
24 papers, 607 citations indexed

About

Taohua Yue is a scholar working on Molecular Biology, Oncology and Biochemistry. According to data from OpenAlex, Taohua Yue has authored 24 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Biochemistry. Recurrent topics in Taohua Yue's work include Sulfur Compounds in Biology (8 papers), Cancer Research and Treatments (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Taohua Yue is often cited by papers focused on Sulfur Compounds in Biology (8 papers), Cancer Research and Treatments (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Taohua Yue collaborates with scholars based in China. Taohua Yue's co-authors include Jing Zhu, Yucun Liu, Shanwen Chen, Pengyuan Wang, Shihao Guo, Zhihao Huang, Shuai Zuo, Yisheng Pan, Dingfang Bu and Jianwen Hu and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and British Journal of Cancer.

In The Last Decade

Taohua Yue

23 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taohua Yue China 15 330 174 158 144 143 24 607
Ju Ma China 13 297 0.9× 189 1.1× 54 0.3× 101 0.7× 46 0.3× 19 487
Diana Farhat France 6 356 1.1× 295 1.7× 63 0.4× 106 0.7× 73 0.5× 7 569
Hongqi Teng United States 10 423 1.3× 171 1.0× 22 0.1× 87 0.6× 123 0.9× 15 598
Weiting Gu China 14 286 0.9× 147 0.8× 21 0.1× 106 0.7× 35 0.2× 29 557
Xiwu Chen United States 10 194 0.6× 93 0.5× 38 0.2× 63 0.4× 37 0.3× 10 444
Sadamu Takano Japan 12 155 0.5× 83 0.5× 50 0.3× 193 1.3× 99 0.7× 28 576
Lina Romero United States 11 327 1.0× 261 1.5× 30 0.2× 93 0.6× 148 1.0× 13 606
Tamara Severi Belgium 9 198 0.6× 85 0.5× 27 0.2× 99 0.7× 38 0.3× 10 604
Rui Zhong China 13 236 0.7× 136 0.8× 46 0.3× 54 0.4× 55 0.4× 37 491

Countries citing papers authored by Taohua Yue

Since Specialization
Citations

This map shows the geographic impact of Taohua Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taohua Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taohua Yue more than expected).

Fields of papers citing papers by Taohua Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taohua Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taohua Yue. The network helps show where Taohua Yue may publish in the future.

Co-authorship network of co-authors of Taohua Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Taohua Yue. A scholar is included among the top collaborators of Taohua Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taohua Yue. Taohua Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yue, Taohua, Yunlong Cai, Jing Zhu, et al.. (2023). Autophagy-related IFNG is a prognostic and immunochemotherapeutic biomarker of COAD patients. Frontiers in Immunology. 14. 1064704–1064704. 8 indexed citations
3.
Yue, Taohua, Jing Zhu, Shuai Zuo, et al.. (2022). Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer. Cancer Research. 83(4). 595–612. 64 indexed citations
4.
Chen, Shan-Wen, Jing Zhu, Shihao Guo, et al.. (2022). Overexpression of CBS/H2S inhibits proliferation and metastasis of colon cancer cells through downregulation of CD44. Cancer Cell International. 22(1). 85–85. 27 indexed citations
5.
Yue, Taohua, Shuai Zuo, Jing Zhu, et al.. (2022). BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer Patients. Frontiers in Cell and Developmental Biology. 9. 799278–799278. 10 indexed citations
6.
Guo, Shihao, Zhihao Huang, Jing Zhu, et al.. (2022). CBS-H2S axis preserves the intestinal barrier function by inhibiting COX-2 through sulfhydrating human antigen R in colitis. Journal of Advanced Research. 44. 201–212. 17 indexed citations
7.
Yue, Taohua, Shuai Zuo, Jing Zhu, et al.. (2021). Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients. Frontiers in Cell and Developmental Biology. 9. 704242–704242. 6 indexed citations
8.
Guo, Shihao, Jichang Li, Zhihao Huang, et al.. (2021). The CBS-H2S axis promotes liver metastasis of colon cancer by upregulating VEGF through AP-1 activation. British Journal of Cancer. 126(7). 1055–1066. 35 indexed citations
9.
Chen, Shanwen, Dingfang Bu, Jing Zhu, et al.. (2021). Endogenous hydrogen sulfide regulates xCT stability through persulfidation of OTUB1 at cysteine 91 in colon cancer cells. Neoplasia. 23(5). 461–472. 37 indexed citations
10.
Ma, Ju, Yongchen Ma, Shanwen Chen, et al.. (2021). SPARC enhances 5-FU chemosensitivity in gastric cancer by modulating epithelial-mesenchymal transition and apoptosis. Biochemical and Biophysical Research Communications. 558. 134–140. 22 indexed citations
11.
Yue, Taohua, Cheng Liu, Jing Zhu, et al.. (2020). Identification of 6 Hub Proteins and Protein Risk Signature of Colorectal Cancer. BioMed Research International. 2020(1). 6135060–6135060. 2 indexed citations
12.
Yue, Taohua, Shuai Zuo, Dingfang Bu, et al.. (2020). Aminooxyacetic acid (AOAA) sensitizes colon cancer cells to oxaliplatin via exaggerating apoptosis induced by ROS. Journal of Cancer. 11(7). 1828–1838. 40 indexed citations
13.
Zhang, Xiaoqian, Long Wen, Shanwen Chen, et al.. (2020). The novel long noncoding RNA CRART16 confers cetuximab resistance in colorectal cancer cells by enhancing ERBB3 expression via miR-371a-5p. Cancer Cell International. 20(1). 68–68. 32 indexed citations
14.
Wen, Long, Xiaoqian Zhang, Junling Zhang, et al.. (2020). Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway. Oncology Reports. 44(3). 1105–1115. 20 indexed citations
15.
Hu, Jianwen, Yongchen Ma, Ju Ma, et al.. (2020). Macrophage-derived SPARC Attenuates M2-mediated Pro-tumour Phenotypes. Journal of Cancer. 11(10). 2981–2992. 14 indexed citations
16.
Wang, Yurong, Lie Sun, Shanwen Chen, et al.. (2019). The administration of Escherichia coli Nissle 1917 ameliorates irinotecan–induced intestinal barrier dysfunction and gut microbial dysbiosis in mice. Life Sciences. 231. 116529–116529. 49 indexed citations
17.
Chen, Shanwen, Taohua Yue, Zhihao Huang, et al.. (2019). Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells. Cancer Letters. 466. 49–60. 47 indexed citations
18.
Ma, Yongchen, Jing Zhu, Shanwen Chen, et al.. (2019). Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancer. Cancer Cell International. 19(1). 137–137. 35 indexed citations
20.
Ma, Yongchen, Jing Zhu, Shanwen Chen, et al.. (2018). Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer. Cancer Cell International. 18(1). 104–104. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026